Dr. Mankoff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
Philadelphia, PA 19104Phone+1 215-614-1926Fax+1 215-349-5843
Education & Training
- University of WashingtonResidency, Nuclear Medicine, 1992 - 1995
- University of WashingtonResidency, Internal Medicine, 1990 - 1992
- Perelman School of Medicine at the University of PennsylvaniaClass of 1988
Certifications & Licensure
- NJ State Medical License 2014 - 2025
- WA State Medical License 1990 - 2025
- PA State Medical License 2012 - 2024
- American Board of Nuclear Medicine Nuclear Medicine
Awards, Honors, & Recognition
- Komen Scholar Susan G. Komen Foundation
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Phase II Trial of 64Cu-ATSM PET/CT in Cervical Cancer Start of enrollment: 2009 Jul 29
- MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme Start of enrollment: 2009 Aug 24
- Fluorine F 18 Sodium Fluoride Positron Emission Tomography in Evaluating Response to Dasatinib in Patients With Prostate Cancer and Bone Metastases Start of enrollment: 2009 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 182 citationsA definition of molecular imagingDavid A. Mankoff
Journal of Nuclear Medicine. 2007-06-01 - 70 citationsQuantitative assessment of dynamic PET imaging data in cancer imagingMark Muzi, Finbarr O'Sullivan, David A. Mankoff, Robert K. Doot, Larry Pierce
Magnetic Resonance Imaging. 2012-11-01 - 81 citationsACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI.Elizabeth R. Gerstner, Zheng Zhang, James R. Fink, Mark Muzi, Lucy Hanna
Clinical Cancer Research. 2016-10-15
Journal Articles
- Test-Retest Reproducibility of FDG-PET/CT Uptake in Cancer Patients Within a Qualified and Calibrated Local NetworkJennifer M Specht, Jean H Lee, Hannah M Linden, Andrew T Shields, David A Mankoff, Paul E Kinahan, Journal of Nuclear Medicine
- Glutamate-Weighted Chemical Exchange Saturation Transfer Magnetic Resonance Imaging (GluCEST MRI) Detects Glutaminase Inhibition in a Mouse Model of Triple-Negative Br...Ravinder Reddy, David Mankoff, Clinical Cancer Research
Press Mentions
- GE HealthCare Announces FES PET Imaging Recommendation in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)May 24th, 2023
- How One Doctor-Patient Relationship Could Change How Women Are Treated for Gynecologic CancersFebruary 2nd, 2023
- Awards & Accolades: May 2021June 9th, 2021
- Join now to see all
Grant Support
- Advanced PET/CT Imaging For Improving Clincail TrialsNational Cancer Institute2010–2012
- PET To Measure Breast Cancer Bone Metastasis ResponseNational Cancer Institute2007–2011
- Estrogen Receptor Positive Breast Cancer And Its Response To TherapyNational Cancer Institute2007–2008
- Estrogen Receptor Positive Breast Cancer And TherapyNational Cancer Institute2004–2006
- Imaging The Response Of Locally Advanced Breast CancerNational Cancer Institute1996–2006
- Diagnosis Of IM Nodal Metastases In Breast CancerNational Cancer Institute2001–2004
- Imaging For Evaluation Of Clinical Vaccine EfficacyNational Cancer Institute2001–2002
- PET Imaging Of Estrogen Receptors In Breast CancerNational Cancer Institute1998–2002
- Positron Tomograph Using Optically Coupled DetectorsNational Cancer Institute1990
- Single-Crystal, Cylindrical Position TomographNational Institute Of Neurological Disorders And Stroke1988
Professional Memberships
- Society of Nuclear Medicine and Molecular ImagingMember
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: